FDA Grants Accelerated Approval for New Cancer Drug Repotrectinib
WASHINGTON, D.C. — On Thursday, the Food and Drug Administration granted accelerated approval to repotrectinib (AUGTYRO), a new drug for treating certain advanced solid tumors in patients aged 12 and …
FDA Grants Accelerated Approval for New Cancer Drug Repotrectinib Read More